Patricia L. Andres

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 607 citations · Full text

Medicine, Neurology, Pharmacology +17

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 524 citations · Full text

Medicine, Neurology, Pharmacology +14

Activity Outcome Measurement for Postacute Care

Stephen M. Haley, Wendy J. Coster, Patricia L. Andres et al. · Medical Care · 2003 · 252 citations

Health Professions, Rehabilitation Medicine, Differential Item Functioning +13

Quantitative motor assessment in amyotrophic lateral sclerosis

Patricia L. Andres, Winifred Hedlund, Lorenz J. Finison et al. · Neurology · 1986 · 207 citations

Life Sciences, Neurology, Neuroscience +17

Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>

Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson et al. · Muscle & Nerve · 2020 · 180 citations · Full text

Medicine, Neurology, Pharmacology +15